Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

PHASE3CompletedINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

December 22, 2005

Primary Completion Date

May 5, 2008

Study Completion Date

May 5, 2008

Conditions
Ulcerative Colitis
Interventions
DRUG

Encapsulated Mesalamine Granules (eMG)

eMG capsules will be administered per dose and schedule specified in the arm.

Trial Locations (61)

10128

Simon Lichtiger, M.D., New York

11768

VA Medical Center, Northport, Northport

12180

Upstate Gastroenterology Associates, PC, Troy

13210

VA Medical Center, Syracuse

20636

Philip J. Beam Medical Center, Hollywood

21215

Sinai Medical Office Building, Baltimore

23320

Gastroenterology Associates of Tidewater, Chesapeake

24073

New River Research Institute, Christiansburg

27262

Bethany Medical Center, High Point

27403

LeBauer Research Associates, PA, Greensboro

27804

Boice-Willis Clinic, Rocky Mount

29414

Charleston Gastroenterology Specialists, LLC, Charleston

29681

Hillcrest Clinical Research, LLC, Simpsonville

30033

Center for Gastroenterology, Decatur

30106

Digestive Care Associates, Austell

30308

Consultative Gastroenterology, Atlanta

31201

Gastroenterology Associates of Central Georgia, Macon

32168

United Medical Research, New Smyrna Beach

32174

Penninsula Research, Inc., Ormond Beach

33013

Medical Research Unlimited, Hialeah

33021

Southern Clinical Research Consultants, Hollywood

33162

Venture Research Institute, LLC, North Miami Beach

33401

Metabolic Research Institute, Inc., West Palm Beach

34233

Lovelace Scientific Resources, Sarasota

34239

Advent Clinical Research, Sarasota

34613

Clinical Research of Tampa Bay, Inc., Brooksville

34684

Advanced Gastroenterology Associates, Palm Harbor

35209

Birmingham Gastroenterology Associates, Birmingham

37205

Medical Research Institute, Nashville

40202

University of Louisville, Louisville

44484

Avamar Center for Endoscopy, Warren

45219

Consultants for Clinical Research, Inc., Cincinnati

48047

Research Institute of Michigan, LLC, Chesterfield

50702

Covenant Clinic, Waterloo

53215

Center for Advanced Research, Milwaukee

60005

Northwest Gastroenterologists S.C., Arlington Heights

63128

St. Louis Center for Clinical Research, St Louis

65265

Center for Digestive & Liver Diseases, Mexico

66606

Cotton-O'Neil Digestive Health Center, Topeka

72205

Little Rock Diagnostic Clinic, Little Rock

72701

First Care Family Doctors South, Fayetteville

74104

Oklahoma Gastroenterology Associates, LLC, Tulsa

77034

NationsMed Clinical Research, Houston

77074

Clinical Trial Network, Houston

77090

Houston Digestive Disease Clinic, Houston

80120

Professionals for Clinical Research, Littleton

90211

Lovelace Scientific Resources, Beverly Hills

90822

Long Beach VA Medical Center, Long Beach

92704

Lovelace Scientific Resources, Santa Ana

92801

AGMG Clinical Research, Anaheim

92840

Digestive Liver Disease Specialists, Medical Group, Garden Grove

92868

Community Clinical Trials, Orange

93108

Santa Barbara Clinical Research, Santa Barbara

94117

Rider Research Group, San Francisco

94901

John Jolley, M.D., San Rafael

98133

Seattle Gastroenterology Associates, Seattle

98405

Digestive Disease Research Center, Tacoma

99204

Eastern Washington Clinical Research Center, Spokane

Spokane Digestive Disease Center, Spokane

06010

Connecticut Gastroenterology Institute, Bristol

07712

Shore Health Group, Ocean City

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00326209 - Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission | Biotech Hunter | Biotech Hunter